Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Effect of smoking on use of antibacterials: a 9-year follow-up study of 24 000 working-aged Finns.

Koskenvuo K, Huunan-Seppälä A, Keistinen T, Autti-Rämö I, Laitinen LA, Koskenvuo M.

Tob Control. 2013 Jul;22(4):280-6. doi: 10.1136/tobaccocontrol-2011-050128. Epub 2012 Jan 17.

PMID:
22253002
2.

Attenuated expression of tenascin-C in ovalbumin-challenged STAT4-/- mice.

Meuronen A, Karisola P, Leino M, Savinko T, Sirola K, Majuri ML, Piirilä P, Virtanen I, Mäkelä M, Laitinen A, Laitinen LA, Alenius H.

Respir Res. 2011 Jan 4;12:2. doi: 10.1186/1465-9921-12-2.

3.

Smoking strongly predicts disability retirement due to COPD: the Finnish Twin Cohort Study.

Koskenvuo K, Broms U, Korhonen T, Laitinen LA, Huunan-Seppälä A, Keistinen T, Autti-Rämö I, Kaprio J, Koskenvuo M.

Eur Respir J. 2011 Jan;37(1):26-31. doi: 10.1183/09031936.00008910. Epub 2010 Jun 1.

4.

Biological and genetic interaction between tenascin C and neuropeptide S receptor 1 in allergic diseases.

Orsmark-Pietras C, Melén E, Vendelin J, Bruce S, Laitinen A, Laitinen LA, Lauener R, Riedler J, von Mutius E, Doekes G, Wickman M, van Hage M, Pershagen G, Scheynius A, Nyberg F, Kere J; PARSIFAL Genetics Study Group.

Hum Mol Genet. 2008 Jun 1;17(11):1673-82. doi: 10.1093/hmg/ddn058. Epub 2008 Feb 27.

5.

Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report.

Pietinalho A, Kinnula VL, Sovijärvi AR, Vilkman S, Säynäjäkangas O, Liippo K, Kontula E, Laitinen LA.

Respir Med. 2007 Jul;101(7):1419-25. Epub 2007 Mar 13.

6.

Downstream target genes of the neuropeptide S-NPSR1 pathway.

Vendelin J, Bruce S, Holopainen P, Pulkkinen V, Rytilä P, Pirskanen A, Rehn M, Laitinen T, Laitinen LA, Haahtela T, Saarialho-Kere U, Laitinen A, Kere J.

Hum Mol Genet. 2006 Oct 1;15(19):2923-35. Epub 2006 Aug 22.

PMID:
16926187
7.

A 10 year asthma programme in Finland: major change for the better.

Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, Nieminen MM, Kontula E, Laitinen LA.

Thorax. 2006 Aug;61(8):663-70.

8.

Predictors of COPD symptoms: does the sex of the patient matter?

Watson L, Schouten JP, Löfdahl CG, Pride NB, Laitinen LA, Postma DS; European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

Eur Respir J. 2006 Aug;28(2):311-8. Epub 2006 May 17.

9.

Neuropeptide S and G protein-coupled receptor 154 modulate macrophage immune responses.

Pulkkinen V, Majuri ML, Wang G, Holopainen P, Obase Y, Vendelin J, Wolff H, Rytilä P, Laitinen LA, Haahtela T, Laitinen T, Alenius H, Kere J, Rehn M.

Hum Mol Genet. 2006 May 15;15(10):1667-79. Epub 2006 Apr 6.

PMID:
16600990
10.

Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.

Watson L, Vonk JM, Löfdahl CG, Pride NB, Pauwels RA, Laitinen LA, Schouten JP, Postma DS; European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

Respir Med. 2006 Apr;100(4):746-53. Epub 2005 Sep 30.

11.

Characterization of GPRA, a novel G protein-coupled receptor related to asthma.

Vendelin J, Pulkkinen V, Rehn M, Pirskanen A, Räisänen-Sokolowski A, Laitinen A, Laitinen LA, Kere J, Laitinen T.

Am J Respir Cell Mol Biol. 2005 Sep;33(3):262-70. Epub 2005 Jun 9.

PMID:
15947423
12.

Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.

Laitinen A, Lindqvist A, Halme M, Altraja A, Laitinen LA.

J Allergy Clin Immunol. 2005 Feb;115(2):259-65.

PMID:
15696079
13.

Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes.

Pykäläinen M, Kinos R, Valkonen S, Rydman P, Kilpeläinen M, Laitinen LA, Karjalainen J, Nieminen M, Hurme M, Kere J, Laitinen T, Lahesmaa R.

J Allergy Clin Immunol. 2005 Jan;115(1):80-7.

PMID:
15637551
14.

Effects of extracts of commonly consumed food supplements and food fractions on the permeability of drugs across Caco-2 cell monolayers.

Laitinen LA, Tammela PS, Galkin A, Vuorela HJ, Marvola ML, Vuorela PM.

Pharm Res. 2004 Oct;21(10):1904-16.

PMID:
15553239
15.

[Sustained reduction in bronchial hyperresponsiveness within three days of inhaled fluticasone propionate in mild asthma:time course after onset and cessation of treatment].

Sovijärvi AR, Haahtela T, Ekroos HJ, Lindqvist A, Saarinen A, Poussa T, Laitinen LA.

Duodecim. 2004;120(13):1591-3. Finnish. No abstract available.

PMID:
15326966
16.

Association study of 15 novel single-nucleotide polymorphisms of the T-bet locus among Finnish asthma families.

Ylikoski E, Kinos R, Sirkkanen N, Pykäläinen M, Savolainen J, Laitinen LA, Kere J, Laitinen T, Lahesmaa R.

Clin Exp Allergy. 2004 Jul;34(7):1049-55.

PMID:
15248849
17.

Characterization of a common susceptibility locus for asthma-related traits.

Laitinen T, Polvi A, Rydman P, Vendelin J, Pulkkinen V, Salmikangas P, Mäkelä S, Rehn M, Pirskanen A, Rautanen A, Zucchelli M, Gullstén H, Leino M, Alenius H, Petäys T, Haahtela T, Laitinen A, Laprise C, Hudson TJ, Laitinen LA, Kere J.

Science. 2004 Apr 9;304(5668):300-4.

18.

Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthma.

Karjalainen EM, Lindqvist A, Laitinen LA, Kava T, Altraja A, Halme M, Laitinen A.

Respir Med. 2003 Sep;97(9):1045-51.

20.
21.

Sleep apnoea: Finnish National guidelines for prevention and treatment 2002-2012.

Laitinen LA, Anttalainen U, Pietinalho A, Hämäläinen P, Koskela K; Expert Advisory Group Listed in Foreword.

Respir Med. 2003 Apr;97(4):337-65.

22.

Respiratory symptoms and asthma in relation to cold climate, inhaled allergens, and irritants: a comparison between northern and southern Finland.

Kotaniemi JT, Pallasaho P, Sovijärvi AR, Laitinen LA, Lundbäck B.

J Asthma. 2002 Oct;39(7):649-58.

PMID:
12442955
23.

Short-term variability of exhaled nitric oxide in young male patients with mild asthma and in healthy subjects.

Ekroos H, Karjalainen J, Sarna S, Laitinen LA, Sovijärvi AR.

Respir Med. 2002 Nov;96(11):895-900.

24.

Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn.

Pallasaho P, Lundbäck B, Meren M, Kiviloog J, Loit HM, Larsson K, Laitinen LA.

Respir Med. 2002 Oct;96(10):759-69.

25.

Physical map of an asthma susceptibility locus in 7p15-p14 and an association study of TCRG.

Polvi A, Polvi T, Sevon P, Petäys T, Haahtela T, Laitinen LA, Kere J, Laitinen T.

Eur J Hum Genet. 2002 Oct;10(10):658-65.

26.

Investigative bronchoscopy and endobronchial biopsy is well tolerated in hyperreactive asthma patients.

Tapanainen L, Lindqvist A, Halme M, Laitinen LA.

Respir Med. 2002 Jun;96(6):466-8.

27.

Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler.

Johnell O, Pauwels R, Löfdahl CG, Laitinen LA, Postma DS, Pride NB, Ohlsson SV.

Eur Respir J. 2002 Jun;19(6):1058-63.

28.

Does non-responder bias have a significant effect on the results in a postal questionnaire study?

Kotaniemi JT, Hassi J, Kataja M, Jönsson E, Laitinen LA, Sovijärvi AR, Lundbäck B.

Eur J Epidemiol. 2001;17(9):809-17.

PMID:
12081098
29.

[Genetics of asthma and atopy--how to interpret results from the candidate gene studies?].

Laitinen T, Laitinen LA, Kere J.

Duodecim. 2000;116(16):1743-9. Review. Finnish. No abstract available.

PMID:
12001452
30.

Perinatal risk factors for hay fever--a study among 2550 Finnish twin families.

Räsänen M, Kaprio J, Laitinen T, Winter T, Koskenvuo M, Laitinen LA.

Twin Res. 2001 Oct;4(5):392-9.

PMID:
11869494
31.

Rebirth of the university hospital: the Finnish strategy.

Laitinen LA, Seppälä A, Kekomäki M.

World Hosp Health Serv. 2001;37(3):12-4, 40, 42.

PMID:
11858005
32.

Sleep-related disordered breathing during pregnancy in obese women.

Maasilta P, Bachour A, Teramo K, Polo O, Laitinen LA.

Chest. 2001 Nov;120(5):1448-54.

PMID:
11713118
33.

Asthma programme in Finland: a community problem needs community solutions.

Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA; Working Group of the Asthma Programme in Finland 1994-2004.

Thorax. 2001 Oct;56(10):806-14. No abstract available.

34.

A second-generation association study of the 5q31 cytokine gene cluster and the interleukin-4 receptor in asthma.

Kauppi P, Lindblad-Toh K, Sevon P, Toivonen HT, Rioux JD, Villapakkam A, Laitinen LA, Hudson TJ, Kere J, Laitinen T.

Genomics. 2001 Sep;77(1-2):35-42.

PMID:
11543630
35.

A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population.

Laitinen T, Daly MJ, Rioux JD, Kauppi P, Laprise C, Petäys T, Green T, Cargill M, Haahtela T, Lander ES, Laitinen LA, Hudson TJ, Kere J.

Nat Genet. 2001 May;28(1):87-91.

PMID:
11326283
36.

Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.

Reichel W, Dahl R, Ringdal N, Zetterstrom O, van den Elshout FJ, Laitinen LA.

Int J Clin Pract. 2001 Mar;55(2):100-6.

PMID:
11321849
37.

Social predictors of adult asthma: a co-twin case-control study.

Huovinen E, Kaprio J, Laitinen LA, Koskenvuo M.

Thorax. 2001 Mar;56(3):234-6.

38.

Increase of asthma in adults in northern Finland?--a report from the FinEsS study.

Kotaniemi JT, Lundbäck B, Nieminen MM, Sovijärvi AR, Laitinen LA.

Allergy. 2001 Feb;56(2):169-74.

PMID:
11167379
39.

The IL9R region contribution in asthma is supported by genetic association in an isolated population.

Kauppi P, Laitinen T, Ollikainen V, Mannila H, Laitinen LA, Kere J.

Eur J Hum Genet. 2000 Oct;8(10):788-92.

40.
41.

Placebo-controlled study of inhaled budesonide on indices of airway inflammation in bronchoalveolar lavage fluid and bronchial biopsies in cross-country skiers.

Sue-Chu M, Karjalainen EM, Laitinen A, Larsson L, Laitinen LA, Bjermer L.

Respiration. 2000;67(4):417-25.

PMID:
10940797
42.

Safety of sputum induction in chronic obstructive pulmonary disease.

Rytilä PH, Lindqvist AE, Laitinen LA.

Eur Respir J. 2000 Jun;15(6):1116-9.

43.

Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine.

Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA.

Am J Respir Crit Care Med. 2000 Jun;161(6):2086-91.

PMID:
10852791
44.

Laminin alpha1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues.

Virtanen I, Gullberg D, Rissanen J, Kivilaakso E, Kiviluoto T, Laitinen LA, Lehto VP, Ekblom P.

Exp Cell Res. 2000 Jun 15;257(2):298-309.

PMID:
10837144
45.

Association study of the chromosomal region containing the FCER2 gene suggests it has a regulatory role in atopic disorders.

Laitinen T, Ollikainen V, Lázaro C, Kauppi P, de Cid R, Antó JM, Estivill X, Lokki H, Mannila H, Laitinen LA, Kere J.

Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):700-6.

PMID:
10712310
46.

Early interventions in asthma with inhaled corticosteroids.

Laitinen LA, Altraja A, Karjalainen EM, Laitinen A.

J Allergy Clin Immunol. 2000 Feb;105(2 Pt 2):S582-5. Review.

PMID:
10669543
47.

Histopathologic features of early and progressive asthma.

Laitinen A, Karjalainen EM, Altraja A, Laitinen LA.

J Allergy Clin Immunol. 2000 Feb;105(2 Pt 2):S509-13. Review.

PMID:
10669533
48.

Perinatal risk factors for asthma in Finnish adolescent twins.

Räsänen M, Kaprio J, Laitinen T, Winter T, Koskenvuo M, Laitinen LA.

Thorax. 2000 Jan;55(1):25-31.

49.

Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study.

Pallasaho P, Lundbäck B, Läspä SL, Jönsson E, Kotaniemi J, Sovijärvi AR, Laitinen LA.

Respir Med. 1999 Nov;93(11):798-809.

Supplemental Content

Loading ...
Support Center